Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Rapamycin in Second-Line Metastatic Osteosarcoma
NCT02429973Phase 2Completed
- Start
- Jul 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of gemcitabine, sirolimus in osteosarcoma (OS). Started Jul 2012; status: completed.
02
Drugs
gemcitabinesirolimus
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT02429973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02429973.